VolitionRX Limited (VNRX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1489 WEST WARM SPRINGS ROAD HENDERSON, NV 89014 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,264 | 20,730 | 10,867 | 20,581 | 19,445 | 16,966 | |||
| Cash and cash equivalent | 3,264 | 20,730 | 10,867 | 20,581 | 19,445 | 16,966 | |||
| Receivables | 111 | 243 | 73 | 13 | 7 | ||||
| Prepaid expense | 339 | 521 | 785 | 598 | 303 | 268 | |||
| Other current assets | 343 | 360 | 448 | 787 | 577 | 323 | |||
| Other undisclosed current assets | |||||||||
| Total current assets: | 4,057 | 21,854 | 12,172 | 21,979 | 20,332 | 17,556 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | (41) | ||||||||
| Operating lease, right-of-use asset | 600 | 550 | 619 | 384 | 326 | 381 | |||
| Property, plant and equipment | 4,429 | 5,523 | 5,393 | 4,911 | 5,171 | 2,981 | |||
| Intangible assets, net (including goodwill) | 314 | 24 | 111 | 217 | 322 | 372 | |||
| Intangible assets, net (excluding goodwill) | 314 | 24 | 111 | 217 | 322 | 372 | |||
| Other undisclosed noncurrent assets | 41 | ||||||||
| Total noncurrent assets: | 5,343 | 6,096 | 6,123 | 5,512 | 5,819 | 3,735 | |||
| TOTAL ASSETS: | 9,400 | 27,950 | 18,295 | 27,490 | 26,151 | 21,291 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,243 | 7,140 | 5,915 | 5,383 | 5,031 | 2,796 | |||
| Accounts payable | 2,766 | 3,211 | 3,043 | 1,542 | 1,540 | 627 | |||
| Accrued liabilities | 3,477 | 3,929 | 2,872 | 3,841 | 3,492 | 2,169 | |||
| Deferred revenue | 230 | 23,000 | 10,000 | ||||||
| Debt | 907 | 1,256 | 1,113 | 798 | 1,081 | 1,003 | |||
| Derivative instruments and hedges, liabilities | |||||||||
| Other undisclosed current liabilities | 411 | 441 | 358 | 335 | 124 | 61 | |||
| Total current liabilities: | 7,791 | 31,837 | 17,386 | 6,516 | 6,237 | 3,860 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 4,281 | 4,025 | 3,215 | 2,782 | 3,361 | 2,935 | |||
| Long-term debt, excluding current maturities | 3,953 | 3,625 | 2,779 | 2,271 | 2,607 | 2,195 | |||
| Finance lease, liability | 328 | 400 | 436 | 511 | 602 | 608 | |||
| Liabilities, other than long-term debt | 411 | 378 | 400 | ||||||
| Deferred revenue | |||||||||
| Operating lease, liability | 411 | 378 | 400 | 152 | 132 | ||||
| Other undisclosed noncurrent liabilities | 23,025 | 423 | 420 | 471 | 260 | 298 | |||
| Total noncurrent liabilities: | 27,717 | 4,826 | 4,036 | 3,252 | 3,620 | 3,233 | |||
| Total liabilities: | 35,507 | 36,663 | 21,422 | 9,768 | 9,857 | 7,093 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (24,908) | (7,802) | (3,127) | 17,722 | 16,294 | 14,199 | |||
| Common stock | 96 | 82 | 58 | 54 | 49 | 41 | |||
| Additional paid in capital | 204,155 | 194,448 | 164,397 | 154,731 | 126,526 | 103,854 | |||
| Accumulated other comprehensive income (loss) | 386 | 244 | 227 | 148 | (60) | 126 | |||
| Accumulated deficit | (229,544) | (202,577) | (167,257) | (136,989) | (110,174) | (89,822) | |||
| Other undisclosed equity, attributable to parent | (552) | (222) | (47) | ||||||
| Equity, attributable to noncontrolling interest | (1,200) | (910) | (222) | ||||||
| Other undisclosed equity | 222 | 47 | |||||||
| Total equity: | (26,108) | (8,712) | (3,127) | 17,722 | 16,341 | 14,199 | |||
| Other undisclosed liabilities and equity | (47) | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 9,400 | 27,950 | 18,295 | 27,490 | 26,151 | 21,291 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,234 | 775 | 306 | 90 | 13 | 17 | ||
| Loss on disposition of assets for financial service operations | (26) | |||||||
| Other income | 1,182 | |||||||
| Cost of revenue (Cost of Product and Service Sold) | (800) | |||||||
| Gross profit: | 1,234 | 775 | 306 | 90 | (787) | 17 | ||
| Operating expenses | (28,258) | (36,763) | (32,086) | (28,423) | (21,261) | (16,060) | ||
| Other undisclosed operating income | 800 | |||||||
| Operating loss: | (27,025) | (35,988) | (31,780) | (28,333) | (21,248) | (16,043) | ||
| Nonoperating income (expense) | (233) | 311 | 1,343 | 849 | (56) | |||
| Other nonoperating income (expense) | (233) | 197 | ||||||
| Interest and debt expense | (222) | (173) | (156) | (130) | 127 | |||
| Loss from continuing operations before income taxes: | (27,258) | (35,899) | (31,953) | (27,146) | (20,529) | (15,972) | ||
| Other undisclosed income from continuing operations | 331 | 177 | ||||||
| Loss from continuing operations: | (27,258) | (35,899) | (31,953) | (26,815) | (20,352) | (15,972) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (26,815) | (20,352) | (15,972) | |
| Other undisclosed net loss | (175) | (127) | ||||||
| Net loss: | (27,258) | (35,899) | (31,953) | (26,990) | (20,352) | (16,099) | ||
| Net income (loss) attributable to noncontrolling interest | 290 | (358) | ||||||
| Other undisclosed net income (loss) attributable to parent | (290) | 580 | 1,355 | (47) | ||||
| Net loss attributable to parent: | (27,258) | (35,677) | (30,598) | (26,990) | (20,399) | (16,099) | ||
| Other undisclosed net income available to common stockholders, basic | 290 | |||||||
| Net loss available to common stockholders, diluted: | (26,968) | (35,677) | (30,598) | (26,990) | (20,399) | (16,099) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (27,258) | (35,899) | (31,953) | (26,990) | (20,352) | (16,099) | ||
| Other comprehensive income (loss) | (26,781) | (20,585) | (16,197) | |||||
| Comprehensive loss: | (27,258) | (35,899) | (31,953) | (53,771) | (40,937) | (32,296) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 290 | (358) | ||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (148) | 596 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (27,116) | (35,660) | (31,953) | (53,771) | (40,937) | (32,296) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.